XM does not provide services to residents of the United States of America.
H
H

Helvetia

News

Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies

BUZZ-Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies ** Vontobel estimates the market potential for obesity drugs in the U.S. to reach a three-digit billion U.S. dollar amount and picks Swiss Re SRENH.S and Ypsomed YPSN.S as the most likely to profit from it ** Among Swiss life insurers, Swiss Re could benefit the most from a rising demand in life and health reinsurance, with a market share of about 15%, as obesity drugs improve life expectancy, it says ** Its posit
B
H
N
R
S
S
Z

Helvetia: Decided To Redeem CHF 225 Mln Hybrid Bond On Its First Optional Redemption Date

BRIEF-Helvetia: Decided To Redeem CHF 225 Mln Hybrid Bond On Its First Optional Redemption Date Sept 17 (Reuters) - Helvetia Holding AG HELN.S : HAS DECIDED TO REDEEM A CHF 225 MILLION HYBRID BOND ON ITS FIRST OPTIONAL REDEMPTION DATE ON 17 OCTOBER 2024 HAS DECIDED TO EXERCISE ITS OPTION TO REDEEM CHF 225 MILLION HYBRID BOND WITH ISIN CH0255893098
H

Investors press Baloise to shake up business after Cevian swoop

Investors press Baloise to shake up business after Cevian swoop By Oliver Hirt and Paul Arnold ZURICH, Sept 10 (Reuters) - Swiss insurer Baloise BALN.S is under pressure to heed shareholder demands to shake up its portfolio and boost returns since activist investor Cevian Capital said it held over 9% of the company's stock, becoming its biggest stakeholder.
A
B
H
A
A
S
Z

Helvetia H1 Underlying Earnings Of CHF 285.2 Mln

BRIEF-Helvetia H1 Underlying Earnings Of CHF 285.2 Mln Sept 5 (Reuters) - HELVETIA HOLDING AG HELN.S : SOLID RESULT AND DISCIPLINED GROWTH – MEASURES TO IMPROVE TECHNICAL PROFITABILITY SHOW INITIAL EFFECTS H1 BUSINESS VOLUME STOOD AT CHF2,529.3 MILLION, THUS GROWING ON A CURRENCY-ADJUSTED BASIS BY 2.3% (FIRST HALF OF 2023: CHF2,486.7 MILLION) H1
H

Swiss stocks - Factors to watch on Thursday, September 5

Swiss stocks - Factors to watch on Thursday, September 5 ZURICH/GDANSK, Sep 5(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: LOGITECH INTERNATIONAL SA LOGN.S Logitech International founder Daniel Borel on Wednesday failed in his attempt to oust Chairperson Wendy Becker, having accused her of failing to provide leadership at the maker of computer mice and keyboards.
H
L
S
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.